These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22559976)

  • 1. Cytogenetic profile of locally advanced and metastatic Schistosoma-related bladder cancer and response to chemotherapy.
    Aly MS; Khaled HM; Emara M; Hussein TD
    Cancer Genet; 2012 Apr; 205(4):156-62. PubMed ID: 22559976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis.
    Khaled HM; Aly MS; Mokhtar N
    Urol Oncol; 2004; 22(6):443-7. PubMed ID: 15610858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal aberrations in early-stage bilharzial bladder cancer.
    Aly MS; Khaled HM
    Cancer Genet Cytogenet; 2002 Jan; 132(1):41-5. PubMed ID: 11801307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic imbalances in Schistosoma-associated and non-Schistosoma-associated bladder carcinoma. An array comparative genomic hybridization analysis.
    Armengol G; Eissa S; Lozano JJ; Shoman S; Sumoy L; Caballín MR; Knuutila S
    Cancer Genet Cytogenet; 2007 Aug; 177(1):16-9. PubMed ID: 17693186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal aberrations in Bilharzial bladder cancer as detected by fluorescence in situ hybridization.
    Aly MS; Khaled HM
    Cancer Genet Cytogenet; 1999 Oct; 114(1):62-7. PubMed ID: 10526537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schistosoma haematobium and bladder cancer: what lies beneath?
    Botelho MC; Machado JC; da Costa JM
    Virulence; 2010; 1(2):84-7. PubMed ID: 21178421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular cytogenetic study of bladder transitional cell carcinoma by FISH].
    Shou J; Wang M; Ma J
    Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):36-8. PubMed ID: 11776593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Numerical aberrations of chromosomes 9 and 11 detected by FISH in Greek bladder cancer patients.
    Panani AD; Babanaraki A; Malianga E; Roussos Ch
    Anticancer Res; 2004; 24(6):3857-61. PubMed ID: 15736422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
    Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
    J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Centrosome hyperamplification predicts progression and tumor recurrence in bladder cancer.
    Yamamoto Y; Matsuyama H; Furuya T; Oga A; Yoshihiro S; Okuda M; Kawauchi S; Sasaki K; Naito K
    Clin Cancer Res; 2004 Oct; 10(19):6449-55. PubMed ID: 15475431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cytogenetic characterization and diagnostics of bladder cancer.
    Houskova L; Zemanova Z; Babjuk M; Melichercikova J; Pesl M; Michalova K
    Neoplasma; 2007; 54(6):511-6. PubMed ID: 17949235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization.
    Hopman AH; Moesker O; Smeets AW; Pauwels RP; Vooijs GP; Ramaekers FC
    Cancer Res; 1991 Jan; 51(2):644-51. PubMed ID: 1985781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder.
    Krüger S; Mess F; Böhle A; Feller AC
    Int J Oncol; 2003 Jul; 23(1):41-8. PubMed ID: 12792774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer.
    Shao L; Lerner SL; Bondaruk J; Czerniak BA; Zeng X; Grossman HB; Spitz MR; Wu X
    Genes Chromosomes Cancer; 2004 Dec; 41(4):379-89. PubMed ID: 15390184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations.
    Zhang FF; Arber DA; Wilson TG; Kawachi MH; Slovak ML
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2317-28. PubMed ID: 9815630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic characterization of the murine bladder cancer model MB49 and the derived invasive line MB49-I.
    Fabris VT; Lodillinsky C; Pampena MB; Belgorosky D; Lanari C; Eiján AM
    Cancer Genet; 2012 Apr; 205(4):168-76. PubMed ID: 22559978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pathological significance of numerical aberrations of chromosomes 11 and 17 in colorectal neoplasms.
    Tagawa Y; Yasutake T; Sawai T; Nanashima A; Jibiki M; Morinaga M; Akama F; Nakagoe T; Ayabe H
    Clin Cancer Res; 1997 Sep; 3(9):1587-92. PubMed ID: 9815847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilharzial vs non-bilharzial related bladder cancer: pathological characteristics and value of cyclooxygenase-2 expression.
    Youssef R; Kapur P; Kabbani W; Shariat SF; Mosbah A; Abol-Enein H; Ghoniem M; Lotan Y
    BJU Int; 2011 Jul; 108(1):31-7. PubMed ID: 21105986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-erb-2 gene amplification and chromosomal anomalies in bladder cancer: preliminary results.
    Leonardo C; Merola R; Orlandi G; Leonardo F; Rondoni M; De Nunzio C
    J Exp Clin Cancer Res; 2005 Dec; 24(4):633-8. PubMed ID: 16471327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.